☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Biliary Tract Cancer
AstraZeneca Reports Results of Imfinzi in P-III TOPAZ-1 Trial as 1L Treatment for Advanced Biliary Tract Cancer
October 26, 2021
Merck KGaA and GSK Discontinue P-II INTR@PID BTC 055 Study of Bintrafusp Alfa as 1L Treatment of Biliary Tract Cancer
August 24, 2021
Incyte's Pemazyre (pemigatinib) Receives MHLW's Approval for Unresectable Biliary Tract Cancer with a FGFR2 Fusion Gene
March 24, 2021
Zymeworks' Zanidatamab Receives the US FDA's Breakthrough Therapy Designation for the Treatment of Biliary Tract Cancer
November 30, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.